Choi Ji-Hee, Park Yun-Gwi, Ju Jongil, Park Soon-Jung, Moon Sung-Hwan
Department of Animal Science and Technology, Chung-Ang University, Anseong, 17546, Korea.
Department of Physics, College of Science and Technology, Dankook University, Cheonan, Chungnam, Korea.
Tissue Eng Regen Med. 2025 May 13. doi: 10.1007/s13770-025-00721-0.
The increasing prevalence of neurodegenerative diseases and toxic substance exposure highlights the need for neuronal cell models that closely mimic human neurons in vivo. Compared to traditional models, human pluripotent stem cell (hPSC)-derived three-dimensional models mimic human physiological characteristics and complex nervous system interactions. These models enable patient-specific treatments and improve the predictive accuracy of drug toxicity evaluations. However, differentiation efficiency varies based on organoid size, structure, and cell line characteristics, necessitating standardized protocols for consistent outcome.
The morphological characteristics of hPSC-derived embryonic bodies (EBs) formed by concave microwells were analyzed at the early stage of neuronal differentiation. Criteria were established to identify cells with high differentiation efficiency, enabling the optimization of differentiation methods applicable across various cell lines. Neuronal organoids were generated using a microfluidic-concave chip, and their suitability for drug toxicity testing was assessed.
EBs, formed in 500 µm concave microwells, exhibited the highest efficiency for neuronal cell differentiation. Cavity-like EBs were more suitable for neuronal differentiation and maturation than cystic-like forms. The optimal neuronal lineage differentiation method was established, and the drug toxicity sensitivity of organoids generated from this method was validated.
This study identified EB structures suitable for neuronal lineage differentiation based on morphological classification. Furthermore, this study suggested an optimal method for generating neuronal organoids. This method can be applied to various cell lines, enabling its precise use in patient-specific treatments and drug toxicity tests.
神经退行性疾病的患病率不断上升以及有毒物质暴露,凸显了建立在体内紧密模拟人类神经元的神经元细胞模型的必要性。与传统模型相比,人类多能干细胞(hPSC)衍生的三维模型可模拟人类生理特征和复杂的神经系统相互作用。这些模型能够实现针对患者的治疗,并提高药物毒性评估的预测准确性。然而,分化效率因类器官大小、结构和细胞系特征而异,因此需要标准化方案以获得一致的结果。
在神经元分化的早期阶段,分析了由凹形微孔形成的hPSC衍生胚状体(EB)的形态特征。建立了识别高分化效率细胞的标准,从而能够优化适用于各种细胞系的分化方法。使用微流控凹形芯片生成神经元类器官,并评估其对药物毒性测试的适用性。
在500 µm凹形微孔中形成的EB表现出最高的神经元细胞分化效率。腔状EB比囊状EB更适合神经元分化和成熟。建立了最佳的神经元谱系分化方法,并验证了用该方法生成的类器官对药物毒性的敏感性。
本研究基于形态学分类确定了适合神经元谱系分化的EB结构。此外,本研究提出了一种生成神经元类器官的最佳方法。该方法可应用于各种细胞系,使其能够精确用于针对患者的治疗和药物毒性测试。